Researchers
reporting in The Lancet on the LiGHT Study concluded that a
change in the clinical practice pattern of how we treat glaucoma should be
implemented so that glaucoma laser
treatment was a first choice treatment, rather than eye drops which is the
typical approach to glaucoma treatment. The LiGHT Study compared eye drops to
glaucoma Selective Laser Trabeculoplasty (SLT) treatment in terms of lowering
intraocular pressure, health related quality of life, cost and cost
effectiveness. The data was gathered and analyzed and concluded that Selective Laser Trabeculoplasty
(SLT) should be offered as a first-line treatment for open angle glaucoma and
ocular hypertension, supporting a change in clinical practice.
If
you or someone you know is at risk for glaucoma, has ocular hypertension or is
being treated for glaucoma, please be certain you have regular eye exams with
glaucoma testing to prevent vision loss. Ask your eye doctor about treatment
options such as SLT for glaucoma when you schedule your exam at The Eye Care & Surgery Center at 908-789-8999, visit The Eye Care &
Surgery Center,
or
facebook.com/eyecareandsurgerycenter to schedule an appointment.
The Eye Care & Surgery Center is an affiliate of Prism Vision
Group and is located at 592
Springfield Avenue, Westfield, New Jersey 07090, 10 Mountain Boulevard, Warren,
New Jersey 07059 and 517 Route One South, Suite 1100, Iselin, New Jersey 08830, and is conveniently located for patients from throughout
central and northern New Jersey.
